A new trading day began on Thursday, with 89bio Inc (NASDAQ: ETNB) stock price up 2.89% from the previous day of trading, before settling in for the closing price of $5.89. ETNB’s price has ranged from $4.16 to $11.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 42.05%. With a float of $140.33 million, this company’s outstanding shares have now reached $145.98 million.
In an organization with 93 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
89bio Inc (ETNB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of 89bio Inc is 3.88%, while institutional ownership is 89.89%. The most recent insider transaction that took place on Apr 15 ’25, was worth 91,208. In this transaction an insider of this company sold 15,329 shares at a rate of $5.95, taking the stock ownership to the 328,323 shares. Before that another transaction happened on Apr 15 ’25, when Company’s Officer proposed sale 15,329 for $5.95, making the entire transaction worth $91,171.
89bio Inc (ETNB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.45% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Here are 89bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.43, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.07 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.39 million. That was inferior than the volume of 2.41 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 76.73%. Additionally, its Average True Range was 0.72.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 24.74%, which indicates a significant decrease from 51.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 140.73% in the past 14 days, which was higher than the 98.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.40, while its 200-day Moving Average is $8.29. However, in the short run, 89bio Inc’s stock first resistance to watch stands at $6.19. Second resistance stands at $6.33. The third major resistance level sits at $6.54. If the price goes on to break the first support level at $5.84, it is likely to go to the next support level at $5.63. Assuming the price breaks the second support level, the third support level stands at $5.49.
89bio Inc (NASDAQ: ETNB) Key Stats
With a market capitalization of 884.66 million, the company has a total of 145,984K Shares Outstanding. Currently, annual sales are 0 K while annual income is -367,080 K. The company’s previous quarter sales were 0 K while its latest quarter income was -118,350 K.
